Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 5
1981 2
1982 4
1983 1
1984 3
1985 6
1986 5
1987 2
1989 3
1990 2
1992 3
1993 3
1994 2
1995 3
1996 4
1997 2
1999 1
2001 1
2002 1
2005 1
2006 1
2007 1
2008 2
2009 2
2011 2
2012 1
2013 3
2014 2
2016 2
2018 1
2019 1
2020 7
2021 7
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis.
Sordi B, Vanderwert F, Crupi F, Gesullo F, Zanotti R, Bonadonna P, Crosera L, Elena C, Fiorelli N, Ferrari J, Grifoni F, Sciumè M, Parente R, Triggiani M, Palterer B, Mecheri V, Almerigogna F, Santi R, Di Medio L, Brandi ML, Iorno ML, Ciardetti I, Bencini S, Annunziato F, Mannarelli C, Pieri L, Guglielmelli P, Mannelli F, Vannucchi AM. Sordi B, et al. Among authors: almerigogna f. J Allergy Clin Immunol. 2023 Feb;151(2):485-493.e11. doi: 10.1016/j.jaci.2022.09.038. Epub 2022 Oct 27. J Allergy Clin Immunol. 2023. PMID: 36309122
Role for CD30 in HIV expression.
Romagnani S, Annunziato F, Manetti R, Almerigogna F, Biagiotti R, Giudizi MG, Ravina A, Giannò V, Tomasévic L, Maggi E. Romagnani S, et al. Among authors: almerigogna f. Immunol Lett. 1996 Jun;51(1-2):83-8. doi: 10.1016/0165-2478(96)02559-x. Immunol Lett. 1996. PMID: 8811349
Anti-severe acute respiratory syndrome coronavirus-2 adenoviral-vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers.
Petito E, Colonna E, Falcinelli E, Mezzasoma AM, Cesari E, Giglio E, Fiordi T, Almerigogna F, Villa A, Gresele P. Petito E, et al. Among authors: almerigogna f. Br J Haematol. 2022 Jul;198(2):257-266. doi: 10.1111/bjh.18245. Epub 2022 May 16. Br J Haematol. 2022. PMID: 35577507
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, Mencarini J, Caporale R, Peruzzi B, Antonelli A, Trotta M, Zammarchi L, Ciani L, Gori L, Lazzeri C, Matucci A, Vultaggio A, Rossi O, Almerigogna F, Parronchi P, Fontanari P, Lavorini F, Peris A, Rossolini GM, Bartoloni A, Romagnani S, Liotta F, Annunziato F, Cosmi L. Mazzoni A, et al. Among authors: almerigogna f. J Clin Invest. 2020 Sep 1;130(9):4694-4703. doi: 10.1172/JCI138554. J Clin Invest. 2020. PMID: 32463803 Free PMC article.
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study.
Vivarelli E, Matucci A, Lucenteforte E, Bormioli S, Virgili G, Trotta M, Spinicci M, Bartoloni A, Zammarchi L, Peris A, Pieralli F, Lavorini F, Fontanari P, Morettini A, Nozzoli C, Poggesi L, Rossi O, Annunziato F, Almerigogna F, Vultaggio A. Vivarelli E, et al. Among authors: almerigogna f. Panminerva Med. 2023 Dec;65(4):473-478. doi: 10.23736/S0031-0808.21.04523-7. Epub 2022 Mar 11. Panminerva Med. 2023. PMID: 35274908
Schnitzler's syndrome: what's new?
Almerigogna F, Giudizi MG, Cappelli F, Romagnani S. Almerigogna F, et al. J Eur Acad Dermatol Venereol. 2002 May;16(3):214-9. doi: 10.1046/j.1468-3083.2002.00458.x. J Eur Acad Dermatol Venereol. 2002. PMID: 12195558 No abstract available.
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity.
Caminati M, Vultaggio A, Matucci A, Senna G, Almerigogna F, Bagnasco D, Chieco-Bianchi F, Cosini F, Girelli D, Guarnieri G, Menzella F, Micheletto C, Olivieri O, Passalacqua G, Pini L, Rossi O, Vianello A, Vivarelli E, Crisafulli E. Caminati M, et al. Among authors: almerigogna f. Respir Med. 2021 Jan;176:106261. doi: 10.1016/j.rmed.2020.106261. Epub 2020 Nov 26. Respir Med. 2021. PMID: 33260107 Free PMC article.
Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center.
Spinicci M, Vellere I, Graziani L, Tilli M, Borchi B, Mencarini J, Campolmi I, Gori L, Rasero L, Fattirolli F, Olivotto I, Lavorini F, Marchionni N, Zammarchi L, Bartoloni A; Careggi Post-acute COVID-19 Study Group. Spinicci M, et al. Open Forum Infect Dis. 2021 Feb 4;8(3):ofab049. doi: 10.1093/ofid/ofab049. eCollection 2021 Mar. Open Forum Infect Dis. 2021. PMID: 34109256 Free PMC article.
89 results